Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer
書誌事項
- 公開日
- 2008
収録刊行物
-
- J Clin Oncol
-
J Clin Oncol 26 5544-5552, 2008